1. Clinical aspects and outcome of lymphoblastic leukemia/lymphoma with cutaneous involvement. (2019) Authors: Bontoux, C.; De Masson, A.; Boccara, O.; Bodemer, C.; Fraitag, S.; Balme, B.; Franck, N.; Carlotti, A.; Comoz, F.; Verneuil, L.; Brasme, J-F.; Duplan, M.; Croué, A.; Templier, I.; Beltraminelli, H.; Dereure, O.; Szablewski, V.; Thevenin, C.; Boulinguez, S.; Viraben, R. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study. Issue 2 (28th January 2021) Authors: Willekens, C.; Rahme, R.; Duchmann, M.; Vidal, V.; Saada, V.; Broutin, S.; Delahousse, J.; Renneville, A.; Marceau, A.; Clappier, E.; Uzunov, M.; Rossignol, J.; Pascal, L.; Simon, L.; Micol, J. B.; Pasquier, F.; Raffoux, E.; Preudhomme, C.; Quivoron, C.; Itzykson, R. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 2(2021) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study. Issue 2 (28th January 2021) Authors: Willekens, C.; Rahme, R.; Duchmann, M.; Vidal, V.; Saada, V.; Broutin, S.; Delahousse, J.; Renneville, A.; Marceau, A.; Clappier, E.; Uzunov, M.; Rossignol, J.; Pascal, L.; Simon, L.; Micol, J. B.; Pasquier, F.; Raffoux, E.; Preudhomme, C.; Quivoron, C.; Itzykson, R. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 2(2021) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. GERMLINE CHEK2 MUTATED MDS PATIENTS. (May 2023) Authors: Freiman, L.; Larcher, L.; Tueur, G.; Vasquez, N.; Da Costa, M.; Raffoux, E.; Ades, L.; Fenaux, P.; Jean, S.; Duployer, N.; Clappier, E.; Sébert, M. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P374: BLINATUMOMAB AS CONSOLIDATION FOR ADULT B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA. A REAL-WORLD STUDY. (23rd June 2022) Authors: Urbino, I.; Lengline, E.; Cerrano, M.; Rabian, F.; Kim, R.; Sebert, M.; Itzykson, R.; Audisio, E.; Ades, L.; Dombret, H.; Raffoux, E.; Ferrero, D.; Clappier, E.; Boissel, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Topic: AS04-MDS Biology and Pathogenesis/AS04e-Spliceosome machinery: DNA REPLICATION STRESS DUE TO LOSS OF R-LOOPS IN MYELODYSPLASTIC SYNDROMES WITH SF3B1 MUTATION. (May 2023) Authors: Rombaut, D.; Lefevre, C.; Farhat, B.; Bondu, S.; Letessier, A.; Lesieur-Pasquier, A.; Castillo-Guzman, D.; Leduc, M.; Hartono, S.; Chesnais, V.; Mangione, R.; Boussaid, I.; Houy, A.; Bouscary, D.; Willems, L.; Chapuis, N.; Kosmider, O.; Park, S.; Raynaud, S.; Cluzeau, T. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: APPLICABILITY OF IPSS-M IN MYELODYSPLASTIC SYNDROMES ARISING FROM APLASTIC ANEMIA AND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. (May 2023) Authors: Gurnari, C.; Prata, P.; Catto, L.F. Bazzo; Durmaz, A.; Larcher, L.; Sébert, M.; Allain, V.; Kewan, T.; Pagliuca, S.; Pinto, A.; Inacio, M.C.B.; Hernandez, L.; Dhedin, N.; Caillat-Zucman, S.; Clappier, E.; De Fontbrune, F.S.; Voso, M.T.; Visconte, V.; De Latour, R. Peffault; Jean, S. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗